Recto Anal Repair or Milligan Morgans Operation of Grade 3 and 4 Symptomatic Haemorrhoidal Disease

NCT ID: NCT01038141

Last Updated: 2014-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare a new mini invasive surgical procedure (Recto Anal Repair) to the traditional Milligan-Morgan procedure in patients suffering from severe piles.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An estimated 4% of the adult population suffers from haemorrhoidal disease. In 1937 E. T. Milligan and C. N. Morgan described a method for operating piles that still is regarded "the gold standard" in the treatment of severe haemorrhoidal disease. This procedure is followed by a prolonged and painful recovery. To overcome the long recovery often combined with long sick leaves, less invasive methods for treating piles have been introduced during the last decade. However, few studies have compared patient benefits and the long term outcome of these techniques, and the choice of treatment is often based on the skills and experience of the individual surgeon. A new and promising mini invasive approach utilizes doppler-guided ligation of the haemorrhoidal arteries. All haemorrhoidal arteries are identified and then ligated approximately 2 cm above the anal canal. Thereafter the rectal mucosa with the piles is repositioned and fixed in the rectum with running sutures. This procedure is termed Recto Anal Repair (RAR) and leads to shrinking of the piles and restored anatomy of the anus and the rectum. The investigators want to execute a randomized, consecutive, prospective, controlled study with long term follow up to compare the RAR procedure to Milligans operation for the treatment of severe haemorrhoidal disease.

The primary goals are evaluation of pain and sick leave 7, 14 and 21 days after surgery and reported reduction of pile symptoms after 3, 6 and 12 months. In addition the investigators want to compare the overall satisfaction with the two procedures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Symptomatic Haemorrhoidal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Milligan Morgan

Group Type ACTIVE_COMPARATOR

Surgery for advanced haemorrhoidal disease

Intervention Type PROCEDURE

Milligan Morgan vs Recto Anal Repair

Recto Anal Repair

Group Type ACTIVE_COMPARATOR

Surgery for advanced haemorrhoidal disease

Intervention Type PROCEDURE

Milligan Morgan vs Recto Anal Repair

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery for advanced haemorrhoidal disease

Milligan Morgan vs Recto Anal Repair

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Transanal doppler-guided hemorrhoidal artery ligation. Transanal hemorrhoidal dearterialization (THD).

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with symptomatic grade 3 and 4 haemorrhoidal disease
* Age 18-80
* Patients who are fitted for local and general anaesthesia
* Patients who are able to understand the information given and are willing to give a written consent

Exclusion Criteria

* Previous operated for piles
* Previous operated in the anal canal
* Faecal incontinence
* Inflammatory bowel disease with affection of the anal canal
* Chronic diarrhea
* Fissura ani
* Fistula in ano
* Chronic anal pain
* Neurological illness with affection of anal sensation
* Patients not able to follow the study protocol
* Patients taking immunosuppressant medication
* Pregnancy
* Disability
* Anal polyps
* Medication affecting the coagulation system
* Circular anal prolapse
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Akershus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Akershus University Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Geir A Larsen, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Akershus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Akershus University Hospital

Lorenskog, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

583-07315a 1.2007.2484(REK)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.